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Abstract
Objective: Osteonecrosis (ON) of the head of femur is not uncommon. The characteristics of affected 
patients and the associated aetiological factors in Nigeria are largely undocumented. To determine the 
epidemiological characteristics of patients with osteonecrosis of the head of femur, the radiological 
severity at presentation and associated aetiological risk factors
Methods: A retrospective study was done, of patients with femoral head ON seen between January 2013 
and January 2019. Data on patients' characteristics, affected hips and radiological severity were entered 
onto a proforma and analysed.
Results: There were 29 patients with ON of the head of femur involving 32 hips. There were 55.2% 
females and 44.8% male patients. While 3 (10.3%) patients had bilateral affectation, 26 (89.7%) had 
unilateral affectation. Their mean age is 26.6years  13.3. The mean age of male and female patients are 
29.3 years and 24.3 years respectively. The mean BMI is 21.9  5.2 and no significant difference in the 
BMI of both genders, p=0.74. Ninety percent of them presented with advanced radiographic stages. 
Factors found to be associated with ON are sickle cell disease (SCD) 44.8%, trauma 13.8%, CVA 3.4% 
and idiopathic cases 37.7%. There is no significant difference in the frequency of unilateral and bilateral 
occurrence in the groups with different hemoglobin genotypes. 
Conclusions: Osteonecrosis of the head of femur occurs more often in young patients. They present late, 
with collapse of the head of femur. SCD, especially HbSS is the most common associated risk factor 
followed by idiopathic cases.
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Ostéonécrose de la tête du fémur dans un hôpital universitaire 
Nigérian
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Résumé 
Objectif: L'ostéonécrose (ON) de la tête du fémur n'est pas rare. Les caractéristiques des patients affectés 
et les facteurs étiologiques associés au Nigeria sont largement non documentés. Déterminer les 
caractéristiques épidémiologiques des patients atteints d'ostéonécrose de la tête du fémur, la gravité 
radiologique à la présentation et les facteurs de risque étiologiques associés
Méthodes : Une étude rétrospective a été faite, des patients avec la tête fémorale observée entre janvier 
2013 et janvier 2019 a été fait. Les données sur les caractéristiques des patients, les hanches affectées et la 
gravité radiologique ont été saisies sur un formulaire et analysées.
Résultats : Il y avait 29 patients avec ON de la tête du fémur impliquant 32 hanches. Il y avait 55,2% de 
femmes et 44,8% de patients masculins. Alors que 3 (10,3%) patients avaient une affectation bilatérale, 26 
(89,7%) avaient une affectation unilatérale. Leur âge moyen est de 26.6 13.3 L'âge moyen des patients 
masculins et féminins est de 29,3 ans et 24,3 ans respectivement. L'IMC moyen est de 21.9 5.2 et aucune 
différence significative dans l'IMC des deux sexes, p = 0,74. Quatre - vingt dix pour cent d'entre eux a 
présenté au stade radiographique avancé. Les facteurs associés à l'ON sont la drépanocytose (SCD) 
44,8%, traumatismes 13,8%, AVC 3,4% et cas idiopathiques 37,7%. Il n'y a pas de différence significative 
entre la fréquence d'occurrence unilatérale et bilatérale dans les groupes avec différents génotypes 
d'hémoglobine.
Conclusion : L'ostéonécrose de la tête du fémur survient plus souvent chez les jeunes patients. Ils se 
présentent tardivement, avec effondrement de la tête du fémur. La drépanocytose, en particulier l'HbSS, 
est le facteur de risque associé le plus courant, suivi des cas idiopathiques.
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INTRODUCTION
Osteonecrosis, also referred to as 
avascular necrosis (AVN) and aseptic necrosis is 
a pathologic condition resulting from 
interruption of blood to bone and its marrow. 
Although this condition can affect various 
anatomic bone parts such as the condyles of the 
femur (knee), head of humerus (shoulder) and the 
talus (ankle), the most common site of affectation 
is the head of femur (1,2,3,4). The ischaemic 
insult that causes death of osteocytes, also 
activates osteoclasts to resorb affected 
subchondral bone (5). Evolution to collapse of 
the head of femur is therefore natural, leading to 
devastating consequences of functional 
impairment. This impairment is worse in patients 
with bilateral hip involvement (6). According to 
Osawa et al (6), patient-reported quality of life in 
patients with bilateral hip disease is worse 
compared with those who have unilateral 
affectation. Children with sickle cell disease and 
ON of the head of femur have been shown to have 
lower quality of life scores globally as well as in 
physical functioning and school functioning 
areas (7). 
Preventing progression to collapse is an 
important major challenge to orthopaedic 
surgeons. To achieve this, there is a need to 
understand the characteristics of the affected 
patients and nature of the disease in our patients 
so that we can institute measures of early 
detection and prevention of progression to 
collapse where possible.   
In Nigeria, epidemiological studies on 
osteonecrosis of the head of femur in general are 
not available. Therefore, the nature of the 
condition, patient characteristics and outcomes 
are largely unknown. The very few available 
studies are limited to patients who have sickle cell 
disease and a case report on association with 
systemic lupus erythematosus (SLE) (8,9,10) 
This study is intended to review existing records 
of patients who had AVN of the head of femur, 
describe their characteristics, radiological 
severity of the condition at presentation and 
associated aetiological risk factors
MATERIALS AND METHODS
This is a retrospective study of 
consequtive patients that were managed for 
osteonecrosis of the head of femur in a tertiary 
hospital. All patients with the diagnosis of 
osteonecrosis, avascular necrosis or aseptic 
necrosis of the head of femur were identified 
from the orthopaedic consultant outpatient clinic 
registers for the study period. Their personal 
information, including hospital numbers were 
extracted and thereafter used to identify and 
retrieve their case files from the medical 
information department of the study centre. 
Each case file was studied, and data 
extracted onto a proforma designed for the 
purpose. Information on personal data, history, 
diagnosis, imaging studies results, and laboratory 
investigations were extracted. No age group was 
exempted from the study.
During the study period, patients with 
known or suspected osteonecrosis were referred 
to the orthopaedic clinic. After clinical 
assessment, each patient had radiographic 
examination of both hips. Complete blood count 
and haemoglobin genotype were also done. 
Magnetic resonance imaging was not routinely 
available. All were given analgesics until 
diagnosis was confirmed when definitive 
treatment was offered.
Data was computerized and analysed 
using Epiinfo version 7 (Centers for Disease 
Control, USA), generating simple frequencies, 
averages and charts. Categorical variables were 
compared by Chi square test with level of 
significance at p < 0.05. 
The study was approved by the scientific 
and ethics review committee of the study centre 
(OOUTH-HREC).
RESULTS
During the study period (January 2013 to 
January 2019), twenty nine patients presented 
with osteonecrosis (ON) of the head of femur 
while 32 hips were affected. There were 16 
females and 13 males (M:F = 1:1.2). As shown in 
table 1, their ages range from 9 years to 67 years. 
Their mean age is 26.6yrs 13.3. The mean age 
of the male patients is 29.3yrs  16.8 while that of 
the female patients is 24.3yrs  9.7. The mean age 
of patients with SCD (HbSS and HbSC) is 17.5 
years (range 9 – 28years) while that of those with 
HbAA is 28.6 years (range 11 – 41 years). The 
mean body mass index (BMI) is 21.9  5.2 (range 
14 – 31.6). There is no significant difference 
between the mean BMI of both genders (21.4 vs 
22.3, p = 0.74)
Twenty six patients (89.7%) presented 
with unilateral ON while 3 (10.3%) had bilateral 
affectation (table 2). Record of haemoglobin 
genotype was available for 20 of the patients. As 
shown in table 3, most of them, 9, have HbSS. 
Seven others have HbAA, 2 HbAS and 2 HbSC. 
There is no significant difference in the frequency 
of hip pain and the bilaterality in the different 
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is compared in the group with HbAA and the 
other genotypes, there is also insignificant 
difference, p = 0.64. All the patients with bilateral 
affectation were in the atraumatic group. Also, 
gender did not affect bilaterality, p = 0.7.
The most common radiographic stage of 
the ON at presentation is Ficat and Arlet stage 3. 
This was seen in 20 of the affected 32 hips 
(62.5%). Nine hips (28.1%) were at stage 4, 2 
hips (6.3%) were stage 2 and only one hip (3.1%) 
was stage 1. Figure 1. That is, 90.6% of the 
patients at presentation, had severe radiographic 
ON (stages 3 and 4) while 19.4% had moderate 
presentation.
The duration of hip pain at presentation 
was 1 to 120 months (mean 23.9months  30.6). 
The modal duration of presentation is 6 months. 
The risk factors for ON in this cohort of patients 
are abnormal genotype (n = 13; 44.8%) 
cerebrovascular accident (CVA) in 1 (3.4%) 
patient and trauma in 4 patients (13.8%), Figure 
2. Trauma was due to fall and being knocked 
down by a motor vehicle (VPA) in 2 patients 
each. Eleven patients (37.7%) had idiopathic ON.
DISCUSSION
Osteonecrosis is commonly described 
affecting the head of femur in patients with sickle 
cell disease. There are no population studies of 
the prevalence of this condition and 
epidemiological characteristics of the condition 
has not been described for the Nigerian patients in 
general. 
The age group of presentation that is 
often reported is 30 to 60 years (1,3,11). From 
India, Vardhan et al reported a mean age of 34.7 
years, range 14-70 (12). From Japan, Kubo et al 
reported mean ages of 30s and 40s for male and 
female patients (13). Lamb et al (11) reported a 
mean age 58years at presentation in the UK. 
However, Adesina et al (14) reported a mean age 
of 27years for SCD patients in California. 
The mean age at presentation in this 
report, 26.6 years, is similar to that in the report of 
Adesina et al but younger than the mean age 
reported from Indian patients, 34.7years (12) and 
30 to 40 years in Japanese series (13). From 
Nigeria, Akinyoola had reported a mean age of 
23.7years from a series of patients with sickle cell 
disease (9). Iwegbu and Fleming in 1989 reported 
a series of 29 patients with sickle cell disease and 
34 affected hips (15). The patients were as young 
as in our report, with an age range of 6years to 
15years. In a series of 24 patients with SCD and 
ON from Brazil, described by Matos et al (7), 
8years was the youngest age of their patients. 
±
While 17% of their patients (Iwegbu and 
Fleming) had bilateral hip affectation, this was 
seen in 10.3% of our patients. This contrasts 
sharply with 86.7% bilaterality from a series of 
SCD patients from Brazil (4). Young patients are 
generally affected most often but these patients 
are even younger in areas like Nigeria and Brazil 
where the prevalence of sickle cell disease is 
high. The affected patients from Nigeria are 
y o u n g e r ,  p r o b a b l y  b e c a u s e  o f  
haemoglobinopathy (9) being the most common 
associated factor as shown in this report. As we 
observed in this report also, it is possible that 
patients with SCD develop ON at a younger age 
(adolescence) compared to others who tend to 
develop this condition in early adulthood.
Male preponderance is usually reported 
for ON of the head of femur (5). The report from 
India indicated five times more prevalence in 
males than females but a M:F ratio of 5:4 in 
Japan. There is no significant difference in the 
affectation of the genders in our patients although 
a slight female preponderance exists at M:F 1:1.2. 
There is a slight preponderance of females being 
affected from Nigeria. A M:F of 1:1.2 in our 
report and 1:1.6 from the report of Iwegbu and 
Fleming. There may be a reason for this 
observation that is still unclear.
Late presentation is seen in this report 
where 90.6% of the patients presented with 
radiographic stages 3 and 4. This is similar to the 
observation of Akinyoola et al in a series of ON in 
patients with sickle cell disease where 81.8% 
presented with stages 3 and 4, Ficat & Arlet (10). 
Symptoms and clinical signs of ON are not 
specific, hence making the diagnosis early is 
difficult. A high index of suspicion is required to 
make the diagnosis early. A deliberate policy of 
early MRI screening of the hips, even though 
relatively very expensive, is required to make 
early diagnosis so as to be able to institute 
treatment aimed at preventing progression to 
collapse of the head of femur. An obvious 
challenge to achieving this is late presentation. 
The average duration of symptoms of hip pain at 
presentation in our patients is 2years. Strategies 
for early diagnosis is needed especially in 
patients with sickle cell disease.
In reports from Europe, North America 
and Asia, the most common associated factors are 
chronic alcoholism and use of steroids (5,12,13). 
Rates of 35% to 51% are reported for steroid use 
while 20% to 31% are reported for alcohol abuse. 
This is unlike in Nigeria where sickle cell disease 
appears to be the most common cause. This also 
explains the younger age of our patients who are 
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born with abnormal haemoglobin genotype 
especially HbSS and HbSC. The Sickle cell trait 
is most common in Nigeria, present in 25% of the 
population (16), and sickle cell disease affects 1 – 
3 percent of the population (17). This explains the 
preponderance of haemoglobinopathy as the 
cause in our patients. It is possible that alcohol 
abuse and steroid use are not as common in our 
patients as in Asians and Caucasians. There may 
be no significant difference in the clinical 
features of the disease in patients with HbSS and 
HbSC (4).
Endothelial dysfunction, leading to 
cardiovascular and cerebrovascular events is an 
important, although uncommon cause of ON 
(18). Only one case, of cerebrovascular accident, 
was found in our patients. 
CONCLUSIONS
Osteonecrosis of the head of femur 
occurs more often in young patients. The disease 
is more often unilateral, and majority of patients 
presents late, with collapse of the head of femur. 
Abnormal haemoglobin genotype, especially 
HbSS is the most common associated risk factor 
followed by idiopathic cases.
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Table 1. Characteristics of 29 patients with hip osteonecrosis 
 
Variable  Frequency   
Sex     
Female 16 55.2%  
Male 13 44.8% M:F=1:1.2 
Age     
Mean 26.6  ± 13.3 years 
Range 9 – 67 years 
BMI   
Mean 21.9 ± 5.2 
Range 14 – 31.6 
Duration of hip pain   
Mean 25.1 ± months 
Range 1 – 120 months 
Mode 6 months 
Affected side   
Unilateral 26 patients 







Table 2. Comparison of gender for affected sides and body mass index 
 
Variable   Male Female Total  
Affected side      
Unilateral 12 14 26  
Bilateral 1 2 3 p=0.68 
Body mass index      







Table 3. Frequency of genotype, affected side and hip pain in 20 patients 
   
 Affected side      
Genotype Bilateral Unilateral     
AA 1 6 
AS 0 2 
SC 0 2 
SS 1 8 p=0.89 
Total 2 18  
   
 Left Hip Pain  Right Hip Pain  
Genotype No Yes No Yes 
AA 2 5 4 3 
AS 1 1  1 1 
SC 1 1  1 1 
SS 1 8  4 5 
Total 8 12 p=0.89 10 10 p=0.97 
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Figure 1. Ficat and Arlet radiographic stages of affected hips 
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